2013
DOI: 10.1097/wco.0b013e328364dc0f
|View full text |Cite
|
Sign up to set email alerts
|

Congenital myasthenic syndromes

Abstract: In addition to the above main points, we also present new data on the genes that were already known with an emphasis on the clinic and on animal models that may be of use to understand the pathophysiology of the disease. We also stress not only the diagnosis difficulties between congenital myopathies and CMSs, but also the continuum that may exist between the two.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
23
0
1

Year Published

2013
2013
2019
2019

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 40 publications
(26 citation statements)
references
References 63 publications
2
23
0
1
Order By: Relevance
“…6 Depending on the localization of the mutated protein, CMSs are classified into four categories: (i) presynaptic compartment CMS, (ii) synaptic basal laminaassociated CMS, (iii) postsynaptic compartment CMS, and (iv) CMS caused by deficient protein glycosylation. Postsynaptic disorders can be divided into two kinetic defects, fast-channel (OMIM 608930) and slow-channel (OMIM 601462) CMSs, and a third disorder, CMS with acetylcholine receptor deficiency (OMIM 608931).…”
Section: Congenital Myasthenic Syndromesmentioning
confidence: 99%
See 2 more Smart Citations
“…6 Depending on the localization of the mutated protein, CMSs are classified into four categories: (i) presynaptic compartment CMS, (ii) synaptic basal laminaassociated CMS, (iii) postsynaptic compartment CMS, and (iv) CMS caused by deficient protein glycosylation. Postsynaptic disorders can be divided into two kinetic defects, fast-channel (OMIM 608930) and slow-channel (OMIM 601462) CMSs, and a third disorder, CMS with acetylcholine receptor deficiency (OMIM 608931).…”
Section: Congenital Myasthenic Syndromesmentioning
confidence: 99%
“…Treatment consists of long-acting open-channel blockers fluoxetine and quinidine; however, the efficacy and tolerability features of these medications are limited. 6 In fast-channel CMSs, receptor activations are brief because acetylcholine receptors do not stay open long enough. These are usually caused by loss-of-function mutations and follow autosomal recessive inheritance.…”
Section: Congenital Myasthenic Syndromesmentioning
confidence: 99%
See 1 more Smart Citation
“…Präsynaptische, synaptische oder postsynaptische Defekte führen zu einer abnorm gesteigerten oder abgeschwächten Antwort an der motorischen Endplatte 28,32,39 .…”
Section: Zusammenfassungunclassified
“…For instance, the study by Maselli et al (2009) demonstrated mutations in laminin-β2 are responsible for a severe form of CMS, which is a neuromuscular disorder characterised by muscle weakness resulting from defects at the NMJ and weakened neurotransmission (Hantai et al, 2004;Engel & Sine, 2005;Maselli et al, 2012).…”
Section: Rationalementioning
confidence: 99%